
David DeNardo WUSM
@denardolabwusm
Professor of Medicine and Immunology
Studying TME-immune interactions and immunotherapy.
ID: 1125156024
https://www.icce-wustl.org/david-denardo-lab.html 27-01-2013 14:11:47
178 Tweet
1,1K Followers
148 Following


Test Account radiation oncologist Julie Schwarz, MD, PhD, (Julie Schwarz) of Siteman has been named a William H. Danforth Washington University Physician Scholar in part for her research to develop new treatments for gynecologic cancers. siteman.wustl.edu/schwarz-named-…




Congratulations Mikala Egeblad and team!


Portrait unveiling at the conclusion of the John F DiPersio Immunotherapy Symposium @WashUOnc Siteman Cancer Center @WUDeptMedicine Test Account Barnes-Jewish @WUSTLdbbs WashU Medicine Division of Physician-Scientists #bmtsm #celltherapy #cartcells #leusm #lymsm #mmsm #mdssm


Congratulations to Bell and Yi on back to back Cancer Discovery papers. Go Sheila Stewart and Siteman Cancer Center aacrjournals.org/cancerdiscover…



Now online in Cancer Discovery: back-to-back papers from the labs of Sheila Stewart and David DeNardo WUSM on immunosuppression by senescent CAFs in breast and pancreatic cancers doi.org/10.1158/2159-8… doi.org/10.1158/2159-8… Jennifer Jiayu Ye Jad Belle #DevashishSen Test Account Siteman Cancer Center


Congratulations Dr. Liu and collaborators Beatty Lab and K.Bryant on their featured article in Science Translational Medicine. And HUDGE THANKS to PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology


Congratulations Dr. Liu Siteman Cancer Center and collaborators Beatty Lab and K.Bryant on their featured article in Science Translational Medicine . And HUDGE THANKS to PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology.


The ChampalimaudF #PancreaticCancer symposium kicks off with an opening lecture by Eileen M O’Reilly Memorial Sloan Kettering Cancer Center on the oncological landscape of available & in development Rx against PDAC. A nod to KRAS targeted therapies, including freshly presented #ENA2024 data.


Dr. Lisa Coussens (LisaCoussens@CoussensLab) is recognized for her paradigm-shifting mechanistic studies on inflammation and cancer that identified B cell and myeloid cell significance in fostering solid tumor progression and hindering therapeutic responses: bit.ly/3A3fIFL


New #OpenAccess from Clinical Cancer Research Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic #PancreaticCancer aacrjournals.org/clincancerres/… Median OS - 13.2 months 1-year survival rate -


📢New human fetal pancreatic organoid model generates all three key cell types of the pancreas. New paper in Cell by Amanda Andersson Rolf , Hans Clevers and collaborators. See the article here: sciencedirect.com/science/articl…


The December issue of Cancer Discovery is now online! The cover features work by Olaf Klingbeil, Christopher Vakoc, and colleagues showing MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer - read that, the year-in-review collection, & more: aacrjournals.org/cancerdiscover…